Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
story of the week

Journal Scan / Research · April 11, 2023

Humoral Immune Response Improves Qualitatively After Repeated COVID Vaccination Despite Anti-CD20 Therapy in Patients With MS

Multiple Sclerosis (Houndmills, Basingstoke, England)


Additional Info

Disclosure statements are available on the authors' profiles:

Multiple Sclerosis (Houndmills, Basingstoke, England)
Humoral immune responses remain quantitatively impaired but improve qualitatively in anti-CD20-treated patients with multiple sclerosis after three or four COVID-19 vaccinations
Mult. Scler. 2023 Mar 28;[EPub Ahead of Print], C Otto, T Schwarz, LM Jeworowski, ML Schmidt, F Walper, F Pache, P Schindler, M Niederschweiberer, A Krumbholz, R Rose, C Drosten, K Ruprecht, VM Corman

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading